APA (7th ed.) Citation

JB, L., C, A., Z, H., H, A., W, S., B, K., . . . MS, A. (2025). A Comparative Real-World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Pharmacoepidemiology and drug safety, 34(3), e70124. https://doi.org/10.1002/pds.70124

Chicago Style (17th ed.) Citation

JB, Layton, Anderson-Smits C, Huang Z, Ay H, Spalding W, Khokhar B, Zhou J, Bennett L, and Anthony MS. "A Comparative Real-World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy." Pharmacoepidemiology and Drug Safety 34, no. 3 (2025): e70124. https://doi.org/10.1002/pds.70124.

MLA (9th ed.) Citation

JB, Layton, et al. "A Comparative Real-World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy." Pharmacoepidemiology and Drug Safety, vol. 34, no. 3, 2025, p. e70124, https://doi.org/10.1002/pds.70124.